Activists are now pressuring the Chilean President to block biotechnology laws from getting into the Parliament.. Chile rejects seed patent legislation referred to as the ‘Monsanto Law’ The Monsanto corporate lobby travels around the world, looking for new seed markets to regulate. Through flattery, biotech reps try to convince government officials to create new seed patent laws and regulations that could increase a country’s agricultural exports and revenue. Biotechnology is certainly marketed as a higher-yield technology for crop production. Some countries’ officials are often hoodwinked and find ways to allow biotech corporations to take over the seed markets through new patenting laws. This drives small and midsized farmers out of production, as GMO control gets control a country’s meals sovereignty and biodiversity in agriculture.‘Though first quarter product sales were mixed, based on current goals and trends, we are assured that revenues for the entire year will be in your previously announced guidance,’ said Kevin Sharer, cEO and chairman. ‘We continue to be encouraged by the lasting ramifications of our cost management efforts. These combined with our revenue and expense expectations place us in your adjusted EPS guidance for the entire year solidly. Most of all, we will sustain a strong R&D purchase as we anticipate disclosing important clinical data in the next 6 to 12 a few months.’ About Amgen Amgen discovers, develops, delivers and manufactures innovative individual therapeutics.